Challenges and prospects for dengue and malaria control in Thailand, Southeast Asia

Trends in Parasitology

Volumn 29, Issue 12, 2013, Pages 623-633

  Corbel, Vincent ^a,b   Nosten, Francois ^c,d   Thanispong, Kanutcharee ^e   Luxemburger, Christine ^f   Kongmee, Monthathip ^g   Chareonviriyaphap, Theeraphap ^b  

^a University de Montpellier   (France)

^b KASETSART UNIVERSITY   (Thailand)

^c SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e MINISTRY OF PUBLIC HEALTH   (Thailand)

^f SANOFI PASTEUR   (France)

^g KASETSART UNIVERSITY   (Thailand)

Author keywords

Control; Dengue; Drugs; Insecticides; Malaria; Resistance; Thailand; Vectors

Indexed keywords

ANTIMALARIAL AGENT; ANTIVIRUS AGENT; ARTEMISININ; DENGUE VACCINE; KAE 609; KAF 156; OZ 439; PRIMAQUINE; TAFENOQUINE; UNCLASSIFIED DRUG;

AEDES AEGYPTI; AEDES ALBOPICTUS; ANOPHELES; ANTIMALARIAL DRUG RESISTANCE; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; BLOOD SMEAR; CASE MANAGEMENT; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DISEASE ELIMINATION; DRUG EFFICACY; ENVIRONMENTAL CHANGE; GENOTYPE; HUMAN; INFECTION CONTROL; INSECTICIDE RESISTANCE; MALARIA; MALARIA CONTROL; MORTALITY; NONHUMAN; PARASITE INCIDENCE; PARASITE PREVALENCE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLASMODIUM; PLASMODIUM FALCIPARUM; REVIEW; SEROTYPE; SINGLE DRUG DOSE; SOUTHEAST ASIA; STUDY; THAILAND; VECTOR CONTROL; VIRUS TRANSMISSION;

CONTROL; DENGUE; DRUGS; INSECTICIDES; MALARIA; RESISTANCE; THAILAND; VECTORS;

ANIMALS; DENGUE; DISEASE VECTORS; HUMANS; INSECT CONTROL; MALARIA; THAILAND;

EID: 84888131316     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.09.007     Document Type: Review

References (96)

1. White N.J., et al. Malaria. Lancet 2013, 10.1016/S0140-6736(13)60024-0.
2. Simmons C.P., et al. Dengue. N. Engl. J. Med. 2012, 366:1423-1432.
3. World Health Organization Dengue: guidelines for diagnosis, treatment, prevention and control. Special Programme for Research and Training in Tropical Diseases 2009, World Health Organization.
4. Bhatt S., et al. The global distribution and burden of dengue. Nature 2013, 496:504-507.
5. Hales S., et al. Potential effect of population and climate changes on global distribution of dengue fever: an empirical model. Lancet 2002, 360:830-834.
6. Benitez M.A. Climate change could affect mosquito-borne diseases in Asia. Lancet 2009, 373:1070.
7. World Health Organization WHO Global Malaria Programme Data WLC-i-P 2012, World Health Organization.
8. Figtree M., et al. Plasmodium knowlesi in human, Indonesian Borneo. Emerg. Infect. Dis. 2010, 16:672-674.
9. McGready R., et al. Effect of early detection and treatment on malaria related maternal mortality on the north-western border of Thailand 1986-2010. PLoS ONE 2012, 7:e40244.
10. Carrara V.I., et al. Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study. PLoS Med. 2013, 10:e1001398.
11. Cui L., et al. Malaria in the Greater Mekong subregion: heterogeneity and complexity. Acta Trop. 2012, 121:227-239.
12. Nisalak A., et al. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am. J. Trop. Med. Hyg. 2003, 68:191-202.
13. Pongsiri P., et al. Changing pattern of dengue virus serotypes in Thailand between 2004 and 2010. J. Health Popul. Nutr. 2012, 30:366-370.
14. Chao D.L., et al. Controlling dengue with vaccines in Thailand. PLoS Negl. Trop. Dis. 2012, 6:e1876.
15. Chen R.F., et al. Different clinical and laboratory manifestations between dengue haemorrhagic fever and dengue fever with bleeding tendency. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:1106-1113.
16. Fried J.R., et al. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl. Trop. Dis. 2010, 4:e617.
17. Wichmann O., et al. Dengue in Thailand and Cambodia: an assessment of the degree of underrecognized disease burden based on reported cases. PLoS Negl. Trop. Dis. 2012, 5:e996.
18. Lumbiganon P., et al. Dengue mortality in patients under 18 years old: an analysis from the health situation analysis of Thai population in 2010 project. J. Med. Assoc. Thai. 2012, 95(Suppl. 7):S108-S113.
19. Clark D.V., et al. Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. Am. J. Trop. Med. Hyg. 2005, 72:786-791.
20. Khamsiriwatchara A., et al. Respondent-driven sampling on the Thailand-Cambodia border. I. Can malaria cases be contained in mobile migrant workers?. Malar. J. 2012, 10:120.
21. Manguin S., et al. Review on global co-transmission of human Plasmodium species and Wuchereria bancrofti by Anopheles mosquitoes. Infect. Genet. Evol. 2010, 10:159-177.
22. Sattabongkot J., et al. Evaluation of the VecTest Malaria Antigen Panel assay for the detection of Plasmodium falciparum and P. vivax circumsporozoite protein in anopheline mosquitoes in Thailand. J. Med. Entomol. 2004, 41:209-214.
23. Putaporntip C., et al. Differential prevalence of Plasmodium infections and cryptic Plasmodium knowlesi malaria in humans in Thailand. J. Infect. Dis. 2009, 199:1143-1150.
24. Strickman D., Kittayapong P. Dengue and its vectors in Thailand: calculated transmission risk from total pupal counts of Aedes aegypti and association of wing-length measurements with aspects of the larval habitat. Am. J. Trop. Med. Hyg. 2003, 68:209-217.
25. Paupy C., et al. Aedes albopictus, an arbovirus vector: from the darkness to the light. Microbes Infect. 2009, 11:1177-1185.
26. Kittayapong P. Malaria and dengue vector biology and control in Southeast Asia. Bridging Laboratory and Field Research for Genetic Control of Disease Vectors 2006, 111-127. Springer Netherlands. B.G. Knols, C. Louis (Eds.).
27. Chareonviriyaphap T., et al. Larval habitats and distribution patterns of Aedes aegypti (Linnaeus) and Aedes albopictus (Skuse), in Thailand. Southeast Asian J. Trop. Med. Public Health 2003, 34:529-535.
28. Bosio C.F., et al. Genetic structure of Aedes aegypti populations in Thailand using mitochondrial DNA. Am. J. Trop. Med. Hyg. 2005, 72:434-442.
29. Rattanarithikul R., et al. Illustrated keys to the mosquitoes of Thailand. IV. Anopheles. Southeast Asian J. Trop. Med. Public Health 2006, 37(Suppl. 2):1-128.
30. Saeung A. Anopheles (diptera:culicidae) species complex in Thailand: identification, distribution, bionomics and malaria-vector importance. Int. J. Parasitol. Res. 2012, 4:75-82.
31. Manguin S. Anopheles Mosquitoes - New Insights into Malaria Vectors 2013, Intech.
32. Thongsahuan S., et al. Susceptibility of Anopheles campestris-like and Anopheles barbirostris species complexes to Plasmodium falciparum and Plasmodium vivax in Thailand. Mem. Inst. Oswaldo Cruz 2011, 106:105-112.
33. Tisgratog R., et al. Host feeding patterns and preference of Anopheles minimus (Diptera: Culicidae) in a malaria endemic area of western Thailand: baseline site description. Parasit. Vectors 2012, 5:114.
34. Obsomer V., et al. The Anopheles dirus complex: spatial distribution and environmental drivers. Malar. J. 2007, 6:26.
35. Yasuoka J., Levins R. Impact of deforestation and agricultural development on anopheline ecology and malaria epidemiology. Am. J. Trop. Med. Hyg. 2007, 76:450-460.
36. Petney T., et al. Potential malaria reemergence, northeastern Thailand. Emerg. Infect. Dis. 2009, 15:1330-1331.
37. Endy T.P., et al. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl. Trop. Dis. 2011, 5:e975.
38. Mammen M.P., et al. Spatial and temporal clustering of dengue virus transmission in Thai villages. PLoS Med. 2008, 5:e205.
39. Rabaa M.A., et al. Frequent in-migration and highly focal transmission of dengue viruses among children in Kamphaeng Phet, Thailand. PLoS Negl. Trop. Dis. 2013, 7:e1990.
40. Yoon I.K., et al. Underrecognized mildly symptomatic viremic dengue virus infections in rural Thai schools and villages. J. Infect. Dis. 2012, 206:389-398.
41. Kittayapong P., et al. Suppression of dengue transmission by application of integrated vector control strategies at sero-positive GIS-based foci. Am. J. Trop. Med. Hyg. 2008, 78:70-76.
42. Esu E., et al. Effectiveness of peridomestic space spraying with insecticide on dengue transmission; systematic review. Trop. Med. Int. Health 2010, 15:619-631.
43. Horstick O., et al. Dengue vector-control services: how do they work? A systematic literature review and country case studies. Trans. R. Soc. Trop. Med. Hyg. 2010, 104:379-386.
44. Chuaycharoensuk T., et al. Frequency of pyrethroid resistance in Aedes aegypti and Aedes albopictus (Diptera: Culicidae) in Thailand. J. Vector Ecol. 2011, 36:204-212.
45. Somwang P., et al. Enzymes-based resistant mechanism in pyrethroid resistant and susceptible Aedes aegypti strains from northern Thailand. Parasitol. Res. 2011, 109:531-537.
46. Yanola J., et al. High-throughput assays for detection of the F1534C mutation in the voltage-gated sodium channel gene in permethrin-resistant Aedes aegypti and the distribution of this mutation throughout Thailand. Trop. Med. Int. Health 2011, 16:501-509.
47. Stevenson B.J., et al. Pinpointing P450s associated with pyrethroid metabolism in the dengue vector, Aedes aegypti: developing new tools to combat insecticide resistance. PLoS Negl. Trop. Dis. 2012, 6:e1595.
48. Strode C., et al. Genomic analysis of detoxification genes in the mosquito Aedes aegypti. Insect Biochem. Mol. Biol. 2008, 38:113-123.
49. Dondorp A.M., et al. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2009, 361:455-467.
50. Phyo A.P., et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet 2012, 379:1960-1966.
51. Saralamba S., et al. Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:397-402.
52. Nosten F. Waking the sleeping beauty. J. Infect. Dis. 2010, 202:1300-1301.
53. Phyo A.P., et al. Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial. Clin. Infect. Dis. 2011, 53:977-984.
54. Guthmann J.P., et al. The efficacy of chloroquine for the treatment of acute, uncomplicated, Plasmodium falciparum malaria in Laos. Ann. Trop. Med. Parasitol. 2002, 96:553-557.
55. White N.J., Imwong M. Relapse. Adv. Parasitol. 2012, 80:113-150.
56. Beier J.C., et al. Integrated vector management for malaria control. Malar. J. 2008, 7(Suppl. 1):S4.
57. Trung H.D., et al. Behavioural heterogeneity of Anopheles species in ecologically different localities in Southeast Asia: a challenge for vector control. Trop. Med. Int. Health 2005, 10:251-262.
58. Chareonviriyaphap T., et al. Review of insecticide resistance and behavioral avoidance of vectors of human diseases in Thailand. Parasit. Vectors 2013, 6:280.
59. Overgaard H.J., et al. Evidence of anopheline mosquito resistance to agrochemicals in northern Thailand. Southeast Asian J. Trop. Med. Public Health 2005, 36(Suppl. 4):152-157.
60. Van Bortel W., et al. The insecticide resistance status of malaria vectors in the Mekong region. Malar. J. 2008, 7:102.
61. Corbel V., N'Guessan R. Distribution, mechanisms, impact and management of insecticide resistance in malaria vectors: a pragmatic review. Anopheles Mosquitoes - New Insights into Malaria Vectors 2013, 579-633. Intech. S. Manguin (Ed.).
62. Sirivichayakul C., et al. Dengue infection in children in Ratchaburi, Thailand: a cohort study. II. Clinical manifestations. PLoS Negl. Trop. Dis. 2012, 6:e1520.
63. Kasper M.R., et al. Infectious etiologies of acute febrile illness among patients seeking health care in south-central Cambodia. Am. J. Trop. Med. Hyg. 2012, 86:246-253.
64. Laoprasopwattana K., et al. Differential diagnosis of Chikungunya, dengue viral infection and other acute febrile illnesses in children. Pediatr. Infect. Dis. J. 2012, 31:459-463.
65. Lam S.K., et al. Call for a World Dengue Day. Lancet 2012, 379:411-412.
66. Hii Y.L., et al. Forecast of dengue incidence using temperature and rainfall. PLoS Negl. Trop. Dis. 2012, 6:e1908.
67. Buczak A.L., et al. A data-driven epidemiological prediction method for dengue outbreaks using local and remote sensing data. BMC Med. Inform. Decis. Mak. 2012, 12:124.
68. Noble C.G., Shi P.Y. Structural biology of dengue virus enzymes: towards rational design of therapeutics. Antiviral Res. 2012, 96:115-126.
69. Thomas S.J., Endy T.P. Vaccines for the prevention of dengue: development update. Hum. Vaccin. 2011, 7:674-684.
70. Guy B., et al. Dengue vaccine prospects: a step forward. Lancet 2011, 377:381-382.
71. Sabchareon A., et al. Efficacy of tetravalent dengue vaccine in Thai schoolchildren - Authors' reply. Lancet 2013, 381:1094-1095.
72. Sumodan P.K. Species diversity of mosquito breeding in rubber plantations of Kerala, India. J. Am. Mosq. Control Assoc. 2012, 28:114-115.
73. Ramasamy R., et al. Larval development of Aedes aegypti and Aedes albopictus in peri-urban brackish water and its implications for transmission of arboviral diseases. PLoS Negl. Trop. Dis. 2011, 5:e1369.
74. Nkya T.E., et al. Impact of environment on mosquito response to pyrethroid insecticides: facts, evidences and prospects. Insect Biochem. Mol. Biol. 2012, 43:407-416.
75. Marcombe S., et al. Pyrethroid resistance reduces the efficacy of space sprays for dengue control on the island of Martinique (Caribbean). PLoS Negl. Trop. Dis. 2011, 5:e1202.
76. Marcombe S., et al. Reduced efficacy of pyrethroid space sprays for dengue control in an area of Martinique with pyrethroid resistance. Am. J. Trop. Med. Hyg. 2009, 80:745-751.
77. Devine G.J., et al. Using adult mosquitoes to transfer insecticides to Aedes aegypti larval habitats. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:11530-11534.
78. Harris A.F., et al. Field performance of engineered male mosquitoes. Nat. Biotechnol. 2011, 29:1034-1037.
79. Walker T., et al. The wMel Wolbachia strain blocks dengue and invades caged Aedes aegypti populations. Nature 2011, 476:450-453.
80. Hoffmann A.A., et al. Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission. Nature 2011, 476:454-457.
81. Charman S.A., et al. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4400-4405.
82. Rottmann M., et al. Spiroindolones, a potent compound class for the treatment of malaria. Science 2010, 329:1175-1180.
83. White N.J., et al. Averting a malaria disaster. Lancet 1999, 353:1965-1967.
84. Douglas N.M., et al. Artemisinin combination therapy for vivax malaria. Lancet Infect. Dis. 2010, 10:405-416.
85. Walsh D.S., et al. Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand. J. Infect. Dis. 1999, 180:1282-1287.
86. Morel C.M., et al. Cost-effectiveness of long-lasting insecticide-treated hammocks in preventing malaria in South-central Vietnam. PLoS ONE 2013, 8:e58205.
87. Hill N., et al. Plant based insect repellent and insecticide treated bed nets to protect against malaria in areas of early evening biting vectors: double blind randomised placebo controlled clinical trial in the Bolivian Amazon. BMJ 2007, 335:1023.
88. Achee N.L., et al. Spatial repellents: from discovery and development to evidence-based validation. Malar. J. 2012, 11:164.
89. Ogoma S.B., et al. Screening mosquito house entry points as a potential method for integrated control of endophagic filariasis, arbovirus and malaria vectors. PLoS Negl. Trop. Dis. 2010, 4:e773.
90. Poinsignon A., et al. First attempt to validate the gSG6-P1 salivary peptide as an immuno-epidemiological tool for evaluating human exposure to Anopheles funestus bites. Trop. Med. Int. Health 2010, 15:1198-1203.
91. Sagna A.B., et al. Plasmodium falciparum infection during dry season: IgG responses to Anopheles gambiae salivary gSG6-P1 peptide as sensitive biomarker for malaria risk in Northern Senegal. Malar. J. 2013, 12:301.
92. Drame P.M., et al. Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific anopheles salivary biomarker. PLoS ONE 2013, 8:e66354.
93. Corbel V., et al. Synergies in integrated malaria control - authors' reply. Lancet Infect. Dis. 2013, 13:112-113.
94. World Health Organization Report of the WHO Informal Consultation Tests Procedures for Insecticide Resistance Monitoring in Malaria Vectors, Bio-efficacy and Persistence of Insecticides on Treated Surfaces 1998, World Health Organization: Parasitic Diseases and Vector Control (PVC)/Communicable Disease Control, Prevention and Eradication (CPE).
95. World Health Organization Test Procedures for Insecticide Resistance Monitoring in Malaria Vector Mosquitoes 2013, World Health Organization.
96. World Health Organization Global Plan for Insecticide Resistance Management in Malaria Vectors (GPIRM) 2012, World Health Organization.